xkcd
Campaigns
TS-Si supports open and immediate access to publicly funded research.
Petition: remove women of transsexual / intersex history from the GLAAD Media Reference Guide. [ sign ]
Read: Andrea Rosenfield's call for reform.
Opening Doors to Transsexual Medical Research
TS-Si
is dedicated to the acceptance, medical
treatment, and legal
protection of individuals correcting the misalignment
of their brains and their anatomical sex, while supporting their transition
into society as hormonally reconstituted and surgically corrected citizens.
is dedicated to the acceptance, medical
treatment, and legal
protection of individuals correcting the misalignment
of their brains and their anatomical sex, while supporting their transition
into society as hormonally reconstituted and surgically corrected citizens.
| How Embryonic Stem Cells Can Develop Into Tissue-specific Cells |
 |
 |
| SciMed - Biology | |||
| TS-Si News Service | |||
| Tuesday, 13 May 2008 18:00 | |||
 Stem Cell Science & Ethics. Opponents of embryonic stem-cell research have objected to two basic scientific techniques that ultimately destroy an embryo:
• harvesting stem cells from 5-day-old human embryos donated by fertilization clinics and creating human embryos using either somatic cell nuclear transfer (SCNT),
Opponents have maintained that scientists should abandon research that destroys embryos and redouble their efforts in other medical research fields, such as non-controversial adult stem-cell studies.
Adult stem cell research involves stem cells found in only certain human tissues — blood, umbilical cord blood, and bone marrow — that have the capacity to regenerate only the tissues from which they originated.
Scientists argued that adult stem-cell research was no substitute for embryonic studies, because the undifferentiated cells in embryos had the unique capacity to develop into pluripotent cells that can make up any organ tissue in the body. In recent research, scientists created what they say appear to be pluripotent cells by coaxing or “reprogramming” adult skin cells to revert to an embryonic stem-cell-like state referred to as induced pluripotent cells. The new skin-cell technique produces stem cells with the same DNA as the donor, and some scientists believe it renders SCNT moot.
In 1998, a team lead by James Thompson at the University of Wisconsin (UW) was the first to successfully harvest pluripotent stem cells from embryos donated by fertilization clinics. Since then, scientists have developed some 400 embryonic stem-cell lines using private and public research funds. Thompson’s lab houses the majority of federally-approved stem-cell lines and his skin-cell research — considered non-controversial from the outset. The lab was funded in part by the US National Institutes of Health (NIH).
In addition to avoiding the ethical controversy over creating and destroying embryos, some critics have pointed out that further refinements to the the new technique could acquire the cumbersome process of acquiring donated eggs and embryos.
However, the “reprogramming” has so far induced the pluripotent cells to become stem cell "like" state with no proof of absolute identity. Subsequent research has suggested that stem cells are more variable in type — and prone to subtle differences — than reflected in the earlier, simpler, definitions.
The collaborative research group, which included Dr. Eran Meshorer of the Department of
 Genetics at the Alexander Silberman Institute of Life Sciences at the Hebrew University of Jerusalem, has revealed that the embryonic stem (ES) cells express large proportions of their genome "promiscuously." Global
Transcription in Pluripotent Embryonic Stem Cells. Sol Efroni, Radharani Duttagupta, Jill Cheng, Hesam Dehghani, Daniel J. Hoeppner, Chandravanu Dash, David P. Bazett-Jones, Stuart Le Grice, Ronald D.G. McKay, Kenneth H. Buetow, Thomas R. Gingeras, Tom Misteli, and Eran Meshorer. Cell Stem Cell 2008 2: 437-447. This permissive expression includes lineage-specific and tissue-specific genes, non-coding regions of the genome that are normally "silent," and repetitive sequences in the genome, which comprise the majority of the mammalian genome but are also normally not expressed. The research findings appear in the latest issue of the journal Cell Stem Cell.  An embryonic stem cell labeled with a DNA-binding dye (blue, left) and a red probe which signals expression of normally silenced repetitive elements (red, right).
Photo courtesy Dr. Eran Meshorer, Hebrew University of Jerusalem.
When embryonic stem (ES) cells differentiate into specific cell tissue-types, they undergo global genetic silencing. But until this occurs, the ES cells maintain an open and active genome. This might very well be the secret of their success, since by maintaining this flexibility they maintain their capacity to become any cell type. Once silencing, or genetic repression, occurs, this ability is gone. Thus, one can say that the ES cells stand at the ready until the "last minute" -- prepared to engage in selective activation into specific cells — holding "in abeyance" their ability to become any kind of cells at the point and time required. To reveal the process as to how this occurs, the researchers created the first full-mouse genomic platform of DNA microarrays.
 The
microarray is a tool consisting of a small membrane or glass slide allow simultaneous detection of thousands of genes. Microarrays contain a very large number of genes in a small space. This makes them useful when studying a small sample or conducting a quick survey of a large number of genes. Microarrays for DNA are small, solid supports — the sequences from thousands of different genes are immobilized, or attached, at fixed locations.
The microarrays used in the study were not confined to specific genes only but spanned the entire genome.
Hundreds of such microarrays were required in the study to cover the entire genome in different time points during stem cell
differentiation. It was by observation of these sequences that the researchers were able to establish exactly how and at what point the stem cells developed into specific tissue cells and when the silencing occurs.
 The TS-Si News Service is a collaborative effort by TS-Si.org editors, contributors, and corresponding institutions. Sources can include the cited individuals and organizations, as well as TS-Si.org staff contributions. Articles and news reports do not necessarily convey official positions of TS-Si, its partners, or affiliates. We welcome your comments. Use the form below to leave a public comment or send private correspondence via the TS-Si Contact Page. We will not divulge any personal details or place you on a mailing list without your permission.TS-Si is dedicated to the acceptance, medical treatment, and legal protection of individuals correcting the misalignment of their brains and their anatomical sex, while supporting their transition into society as hormonally reconstituted and surgically corrected citizens.
Email this
Comments (0)
 Write comment
|
|||
| Last Updated on Tuesday, 13 May 2008 09:58 |
Subscribe to this comment's feed
Show/hide comments
Show/hide comment form
The TS-Si News Service
and the TS-Si Research Service are collaborations of TS-Si officials, staff, contributors, and corresponding institutions. The contents do not necessarily convey official positions of TS-Si or its owners, participants, partners, or affiliates.